Company details
| Name | Y-mabs Therapeutics Limited |
| Number | 13609538 |
| Date of Incorporation: | 2021-09-08 |
| End of financial year: | 30 September |
| Address: | First Floor, 100 Victoria Embankment, London, EC4Y 0DH |
| SIC code: |
72110 - Research and experimental development on biotechnology |
Y-Mabs Therapeutics Limited was dissolved on 2023-08-22.
Y-mabs Therapeutics was a private limited company that was situated at First Floor, 100 Victoria Embankment, London, EC4Y 0DH, ENGLAND. The company (incorporated on 2021-09-08) was run by 1 director.
Director Bo K. who was appointed on 08 September 2021.
The company was classified as "research and experimental development on biotechnology" (72110).
The last confirmation statement was sent on 2022-09-07.
Directors
People with significant control
Y-Mabs Therapeutics, Inc.
8 September 2021
| Address | 230 Park Avenue, Suite 3350, New York, Ny, 10169, United States |
| Legal authority | State Of Delaware |
| Legal form | Corporation |
| Country registered | State Of Delaware |
| Place registered | Division Of Corporations |
| Registration number | 5737747 |
| Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
Filings
Categories:
Confirmation statement
Incorporation
Resolution
| Download filing | |
|---|---|
|
(CS01) Confirmation statement with no updates Wednesday 7th September 2022 filed on: 29th, September 2022 | confirmation statement |
Free Download
(3 pages)
|